|
2023 Journal Article Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patientsLucas, S. E. M., Raspin, K., Mackintosh, J., Glaspole, I., Reynolds, P. N., Chia, C., Grainge, C., Kendall, P., Troy, L., Schwartz, D. A., Wood-Baker, R., Walsh, S. L. F., Moodley, Y., Robertson, J., Macansh, S., Walters, E. H., Chambers, D., Corte, T.J. and Dickinson, J. L. (2023). Preclinical interstitial lung disease in relatives of familial pulmonary fibrosis patients. Pulmonology, 29 (3), 257-260. doi: 10.1016/j.pulmoe.2022.09.002 |
|
2023 Journal Article Sex- and race-based differences in the treatment of interstitial lung diseases in North America And AustralasiaAssayag, Deborah, Adegunsoye, Ayodeji, Sheehy, Robert, Morisset, Julie, Khalil, Nasreen, Johannson, Kerri A., Marcoux, Veronica, Kolb, Martin, Fisher, Jolene H., Manganas, Helene, Wrobel, Jeremy, Wilsher, Margaret, De Boer, Sally, Mackintosh, John, Chambers, Daniel C., Glaspole, Ian, Keir, Gregory J., Lee, Cathryn T., Jablonski, Renea, Vij, Rekha, Strek, Mary E., Corte, Tamera J. and Ryerson, Christopher J. (2023). Sex- and race-based differences in the treatment of interstitial lung diseases in North America And Australasia. Chest, 163 (5), 1156-1165. doi: 10.1016/j.chest.2022.12.039 |
|
2023 Journal Article Laparoscopic fundoplication after lung transplantation does not appear to alter lung function trajectoryFrankel, Adam, Kellar, Trina, Zahir, Farah, Chambers, Daniel, Hopkins, Peter and Gotley, David (2023). Laparoscopic fundoplication after lung transplantation does not appear to alter lung function trajectory. The Journal of Heart and Lung Transplantation, 42 (5), 603-609. doi: 10.1016/j.healun.2022.12.001 |
|
2023 Journal Article Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaireBarnes, Hayley, Chambers, Daniel, Grainge, Chris, Corte, Tamera J., Bastiampillai, Shalini, Frenkel, Simon, Westall, Glen, Collard, Harold and Glaspole, Ian (2023). Clinical utility of a standardized chronic hypersensitivity pneumonitis exposure questionnaire. Respirology, 28 (4), 366-372. doi: 10.1111/resp.14404 |
|
2023 Journal Article Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature reviewDivithotewala, Chandima, Sweeney, Emma L., Burke, Andrew, Graves, Bianca, Stewart, Adam, Whiley, David, Heney, Claire, Hopkins, Peter M. and Chambers, Daniel C. (2023). Mycoplasma hominis and Ureaplasma urealyticum infections in the immediate post-lung transplant period: A case series and literature review. Transplant Infectious Disease, 25 (3) e14058, 1-7. doi: 10.1111/tid.14058 |
|
2023 Journal Article Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic studyPandeya, Nirmala, Huang, Nancy, Jiyad, Zainab, Plasmeijer, Elsemieke I., Way, Mandy, Isbel, Nicole, Campbell, Scott, Chambers, Daniel C., Hopkins, Peter, Soyer, H. Peter, Whiteman, David C., Olsen, Catherine M. and Green, Adele C. (2023). Basal cell carcinomas in organ transplant recipients versus the general population: clinicopathologic study. Archives of Dermatological Research, 315 (4), 771-777. doi: 10.1007/s00403-022-02403-6 |
|
2023 Journal Article Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 studySolomon, Joshua J., Danoff, Sonye K., Woodhead, Felix A., Hurwitz, Shelley, Maurer, Rie, Glaspole, Ian, Dellaripa, Paul F., Gooptu, Bibek, Vassallo, Robert, Cox, P. Gerard, Flaherty, Kevin R., Adamali, Huzaifa, Gibbons, Michael A., Troy, Lauren, Forrest, Ian A., Lasky, Joseph A., Spencer, Lisa G., Golden, Jeffrey, Scholand, Mary Beth, Chaudhuri, Nazia, Perrella, Mark A., Lynch, David A., Chambers, Daniel C., Kolb, Martin, Spino, Cathie, Raghu, Ganesh, Goldberg, Hilary J. and Rosas, Ivan (2023). Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. The Lancet Respiratory Medicine, 11 (1), 87-96. doi: 10.1016/S2213-2600(22)00260-0 |
|
2022 Journal Article Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator eraDavidson, Sarah J., France, Megan, Callaway, Leonie K., Lust, Karin, Chambers, Daniel, Hopkins, Peter, Bell, Scott C., Burr, Lucy, Keating, Rebecca and Barrett, Helen L. (2022). Pregnancy in women with cystic fibrosis and diabetes: an audit of outcomes at two tertiary obstetric hospitals in Australia in the pre-cystic fibrosis transmembrane conductance regulator modulator era. Obstetric Medicine, 16 (4), 217-221. doi: 10.1177/1753495x221146342 |
|
2022 Journal Article Epidemiology, risk factors, and outcomes of lung retransplantation: an analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant RegistryHarhay, Michael O., Cherikh, Wida S., Toll, Alice E., Christie, Jason D., Stehlik, Josef, Chambers, Daniel, Hayes, Don and Cantu, Edward (2022). Epidemiology, risk factors, and outcomes of lung retransplantation: an analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant Registry. The Journal of Heart and Lung Transplantation, 41 (10), 1478-1486. doi: 10.1016/j.healun.2022.06.022 |
|
2022 Journal Article Understanding the pathogenesis of occupational coal and silica dust-associated lung diseaseVanka, Kanth Swaroop, Shukla, Shakti, Gomez, Henry M., James, Carole, Palanisami, Thava, Williams, Kenneth, Chambers, Daniel C., Britton, Warwick J., Ilic, Dusan, Hansbro, Philip Michael and Horvat, Jay Christopher (2022). Understanding the pathogenesis of occupational coal and silica dust-associated lung disease. European Respiratory Review, 31 (165) 210250, 1-17. doi: 10.1183/16000617.0250-2021 |
|
2022 Journal Article Response to: Correspondence on 'Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis' by Hoy et alHua, Jeremy Tang, Zell-Baran, Lauren, Go, Leonard H T., Kramer, Mordechai R, Van Bree, Johanna B, Chambers, Daniel, Newbigin, Katrina, Deller, David, Matula, Michael, Fireman, Elizabeth, Dahbash, Mor, Martinez-Gonzalez, Cristina, León-Jimenez, Antonio, Sack, Coralynn, Ferrer Sancho, Jaume, Villar, Ana, Almberg, Kirsten S., Cohen, Robert A. and Rose, Cecile S (2022). Response to: Correspondence on 'Demographic, exposure and clinical characteristics in a multinational registry of engineered stone workers with silicosis' by Hoy et al. Occupational and Environmental Medicine, 79 (12), 849-850. doi: 10.1136/oemed-2022-108512 |
|
2022 Journal Article A phase IIb randomized study of an anti-αvβ6 monoclonal antibody in idiopathic pulmonary fibrosisRaghu, Ganesh, Mouded, Majd, Chambers, Daniel C., Martinez, Fernando J., Richeldi, Luca, Lancaster, Lisa H., Hamblin, Mark J., Gibson, Kevin F., Rosas, Ivan O., Prasse, Antje, Zhao, Guolin, Serenko, Michael, Novikov, Natasha, McCurley, Amy, Bansal, Prashant, Stebbins, Christopher, Arefayene, Million, Ibebunjo, Stella, Violette, Shelia M., Gallagher, Diana and Behr, Jürgen (2022). A phase IIb randomized study of an anti-αvβ6 monoclonal antibody in idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine, 206 (9), 1128-1139. doi: 10.1164/rccm.202112-2824OC |
|
2022 Journal Article Towards truly ‘idiopathic’ pulmonary fibrosisMackintosh, John A. and Chambers, Daniel C. (2022). Towards truly ‘idiopathic’ pulmonary fibrosis. Respirology, 27 (9), 682-683. doi: 10.1111/resp.14320 |
|
2022 Journal Article Phase 2B study of inhaled RVT-1601 for chronic cough in idiopathic pulmonary fibrosis: a multicenter, randomized, placebo-controlled study (SCENIC Trial)Martinez, Fernando J., Wijsenbeek, Marlies S., Raghu, Ganesh, Flaherty, Kevin R., Maher, Toby M., Wuyts, Wim A., Kreuter, Michael, Kolb, Martin, Chambers, Daniel C., Fogarty, Charles, Mogulkoc, Nesrin, Tutuncu, Ahmet S. and Richeldi, Luca (2022). Phase 2B study of inhaled RVT-1601 for chronic cough in idiopathic pulmonary fibrosis: a multicenter, randomized, placebo-controlled study (SCENIC Trial). American Journal of Respiratory and Critical Care Medicine, 205 (9), 1084-1092. doi: 10.1164/rccm.202106-1485OC |
|
2022 Journal Article Markers of rejection of a lung allograft: state of the artSilva, Tharushi de, Voisey, Joanne, Hopkins, Peter, Apte, Simon, Chambers, Daniel and O'Sullivan, Brendan (2022). Markers of rejection of a lung allograft: state of the art. Biomarkers in Medicine, 16 (6), 483-498. doi: 10.2217/bmm-2021-1013 |
|
2022 Journal Article Genomic lung allograft surveillance: is it primer time?Mackintosh, John A. and Chambers, Daniel C. (2022). Genomic lung allograft surveillance: is it primer time?. The Journal of Heart and Lung Transplantation, 41 (4), 467-469. doi: 10.1016/j.healun.2022.01.016 |
|
2022 Conference Publication Polygenic risk scores in familial IPF implicates rare variantsLucas, S., Raspin, K., Chambers, D., Glaspole, , Reynolds, P., Schwartz, D., Walters, H., Wood-Baker, R., Walsh, S., Moodley, Y., Corte, T. and Dickinson, J. (2022). Polygenic risk scores in familial IPF implicates rare variants. HOBOKEN: WILEY. |
|
2022 Conference Publication Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaireBarnes, H., Chambers, D., Grainge, C., Corte, T., Bastiampillai, S., Frenkel, S., Westall, G., Collard, H. and Glaspole, (2022). Clinical utility of a standardized hypersensitivity pneumonitis exposure questionnaire. HOBOKEN: WILEY. |
|
2022 Conference Publication Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemicMoore, , Wrobel, J., Jackson, D., Mackintosh, J., Glaspole, , Grainge, C., Wilsher, M., Thien, F., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Corte, T. (2022). Australia and New Zealand interstitial lung disease registry (ANZ ILD) 2021 update-Progress during the pandemic. HOBOKEN: WILEY. |
|
2022 Conference Publication Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national populationChee, M., Corte, T., Jackson, D., Lee, C., Wrobel, J., Glaspole, , Grainge, C., Wilsher, M., Chambers, D., Goh, N., Edwards, A., Gallagher, H., Kwan, B., Veitch, E., Keir, G. and Thien, F. (2022). Idiopathic pulmonary fibrosis-eastern health Victoria benchmarked against national population. HOBOKEN: WILEY. |
